Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Pediatric Dermatology
|
August 27, 2019
Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes
Jiawei Zhao, Amy H Huang, Barbara M Rainer, et al.
Journal of Neural Transmission. Supplementum
|
November 7, 2007
VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly
P Fischer, W Krampla, N Mostafaie, et al.
Pediatric Dermatology
|
October 5, 2016
Retrospective Study of Nasal Infantile Hemangiomas: Characteristics, Complications, and Outcomes
Maria S Kryatova, Barbara M Rainer, Jiawei Zhao, et al.
Amino Acids
|
February 9, 2007
Nano-structured support materials, their characterisation and serum protein profiling through MALDI/TOF-MS
M Najam-Ul-Haq, M Rainer, N Heigl, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1997
Therapeutic results with Cerebrolysin in the treatment of dementia
M Rainer, M Brunnbauer, A Dunky, et al.
Optics Express
|
January 18, 2019
Broadband near-infrared astronomical spectrometer calibration and on-sky validation with an electro-optic laser frequency comb
E Obrzud, M Rainer, A Harutyunyan, et al.
The British Journal of Dermatology
|
May 28, 2014
Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study
G A Okoye, B M Rainer, S G Leung, et al.
International Clinical Psychopharmacology
|
September 13, 2001
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
E Ruether, R Husmann, E Kinzler, et al.
American Journal of Clinical Dermatology
|
September 11, 2019
Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study
Barbara M Rainer, Katherine G Thompson, Corina Antonescu, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's Disease
A Schneeberger, S Hendrix, M Mandler, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Pediatric Dermatology
|
August 27, 2019
Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes
Jiawei Zhao, Amy H Huang, Barbara M Rainer, et al.
Journal of Neural Transmission. Supplementum
|
November 7, 2007
VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly
P Fischer, W Krampla, N Mostafaie, et al.
Pediatric Dermatology
|
October 5, 2016
Retrospective Study of Nasal Infantile Hemangiomas: Characteristics, Complications, and Outcomes
Maria S Kryatova, Barbara M Rainer, Jiawei Zhao, et al.
Amino Acids
|
February 9, 2007
Nano-structured support materials, their characterisation and serum protein profiling through MALDI/TOF-MS
M Najam-Ul-Haq, M Rainer, N Heigl, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1997
Therapeutic results with Cerebrolysin in the treatment of dementia
M Rainer, M Brunnbauer, A Dunky, et al.
Optics Express
|
January 18, 2019
Broadband near-infrared astronomical spectrometer calibration and on-sky validation with an electro-optic laser frequency comb
E Obrzud, M Rainer, A Harutyunyan, et al.
The British Journal of Dermatology
|
May 28, 2014
Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study
G A Okoye, B M Rainer, S G Leung, et al.
International Clinical Psychopharmacology
|
September 13, 2001
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
E Ruether, R Husmann, E Kinzler, et al.
American Journal of Clinical Dermatology
|
September 11, 2019
Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study
Barbara M Rainer, Katherine G Thompson, Corina Antonescu, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's Disease
A Schneeberger, S Hendrix, M Mandler, et al.
Page
of 6